Types of Cancer We Treat

Brain Tumors in Adults

We take on the most difficult to treat brain tumors, including glioblastomas, gliomas, astrocytomas, meningiomas, and metastatic brain tumors. We’re nationally known for providing innovative precision molecular diagnoses for brain tumors, and for our expertise in neurosurgery, neuro-oncology, and Gamma Knife®, a precisely targeted radiation treatment for complex brain tumors. We believe that, in some cases, the standard of care may be outdated and might not be the best treatment for you. That’s why we base your care plan on the tumor’s precise molecular makeup, delivering truly individualized care with compassion. We also design cutting-edge clinical trials to find promising new treatments.

Find a Doctor & Schedule
Glioma & Astrocytoma
Meningioma
Metastatic Brain Tumors

Related News

Research Advances Therapies for Hard-to-Treat Brain Tumors
Read Story
New Intraoperative System Correctly Classifies Brain Tumors
Read Story
New MRI Scanner in the OR Changes the Game for Brain Surgery
Read Story
New Molecular Test to Detect Brain Tumors
Read Story

Clinical Trials and Research Studies

Phase 3

A Randomized Double-Blind Placebo-Controlled Phase 3 Study of Enzastaurin Added to Temozolomide During and Following Radiation Therapy in Newly Diagnosed Glioblastoma Patients Who Possess the Novel Genomic Biomarker DGM1

Learn More

Phase 2

A RANDOMIZED PHASE II/III OPEN-LABEL STUDY OF IPILIMUMAB AND NIVOLUMAB VERSUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MGMT (TUMOR O-6-METHYLGUANINE DNA METHYLTRANSFERASE) UNMETHYLATED GLIOBLASTOMA

Learn More

Phase 2

GENOMICALLY-GUIDED TREATMENT TRIAL IN BRAIN METASTASES

Learn More

Phase 2

ANBL19P1: A Pilot Study of Dinutuximab Sargramostim (GM-CSF) and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma

Learn More
View All Related Clinical Trials (23)